I.Proven invasive candidiasis |
Candidemia with temporally related clinical signs and symptoms compatible with the relevant organism
Candida spp. from sterile site other than (i) urine or (ii) peritoneal fluid in a setting of gastrointestinal perforation
|
II.Probable invasive candidiasis |
Candidemia without the clinical findings of criteria I.1
Candida spp. from ≥2 nonsterile sites in association with all of the following within the preceding or subsequent 3 days (day of positive cultures ± 3 days). If the nonsterile site cultures are obtained on different days, then the time window for the listed supporting factors extends from 3 days before the first positive culture for Candida spp. to 3 days after the last positive culture for Candida spp.:
Temperature ≥ 38.5°C (101.3°F) on at least on occasion
WBC c ≥ 12,000/mm 3 on at least one occasion
No bacterial pathogens at any possibly infected site, with the exception of coagulase-negative staphylococci in the blood or on a catheter tip
Candida spp. from urine at ≥100,000 CFU/ml plus other criteria as in II.2
Candida spp. from a central venous catheter tip at ≥15 CFU in association with all of the following within the preceding or subsequent 3 days (day of positive culture ± 3 days):
Temp ≥ 38.5°C (101.3°F) OR WBC ≥ 12,000/mm3
No bacterial pathogens at any possibly infected site, with the exception of coagulase-negative staphylococci in the blood or on a catheter tip
Empirical treatment with systemic antifungal agents initiated due to a persistent temp of ≥38.5°C (101.3°F) OR WBC ≥ 12,000/mm3 despite ≥3 days of broad-spectrum antibiotics in association with one of the following clinical scenarios:
|
|
Scenario A—the patient shows both of the following:
Candida spp. from at least one nonsterile site OR at least one central venous catheter tip at <15 CFU
No bacterial pathogens at any possibly infected site within the preceding or subsequent 3 days (day of initiation of therapy ± 3 days) with the exception of coagulase-negative staphylococci in the blood or on a catheter tip
|
|
Scenario Ba—the patient has Candida spp. at ≥2 of the following:
Any nonsterile site
A central venous catheter tip at <15 CFU
|
III.Possible invasive candidiasis |
Candida from a central venous catheter tip at ≥15 CFU not satisfying criteria as in II.4b
Empirical treatment as in II.5, but without data satisfying either clinical scenario
|